DeFronzo's 'ominous octet' delineates eight factors contributing to the pathophysiology of type 2 diabetes, advocating combination therapy involving diet, exercise, metformin, thiazolidinediones (TZD), and glucagon-like peptide-1 (GLP-1) receptor agonists. This evidence concerns the gene GCG and type 2 diabetes mellitus.